Aclaris aquires Vixen (JAK inhibitor research) - Bald Truth Talk - Hair Loss, Hair Transplant and Hair Restoration Community

X

lurker77

Junior Member

Join Date: Aug 2012

Posts: 11
Share

Tweet
#1

Aclaris aquires Vixen (JAK inhibitor research)

03-31-2016, 10:46 AM

One article here. Aclaris is a NASDAQ traded company with an estimated value of $55M and an estimated market cap of $350M.

Edit: Basically a repost, can't find a way to delete.
Tags: None

Previous template Next